CLINICAL_TRIALS
trial_result
· 2023-12-01
Clinical Trial Update: Feasibility of Gallium-68-tilmanocept PET/CT for Sentinel Lymph Node Detection in Endometrial Cancer [Phase 3]
Summary
Phase 3 trial assessing feasibility of Gallium-68-tilmanocept PET/CT for sentinel lymph node detection in endometrial cancer.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: UMC Utrecht | Conditions: Endometrial Cancer | Phase 3 | Status: UNKNOWN